ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 971,35
0,17%
Dow Jones
38 675,68
1,18%
DAX
18 036,17
0,24%
Brent Oil
83,435
0,37%
Bitcoin
64 464,09
0,74%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Autolus Therapeutics PLC (AUTL)

  7. Autolus Therapeutics PLC (AUTL) Actualités

AUTL Autolus Therapeutics PLC

4,19
0,00 (0,00%)
06 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Autolus Therapeutics PLC AUTL NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 4,19 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,19
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202416:00GLOBEAbstract for longer-term follow-up and additional data..
23/4/202413:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02/4/202413:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01/4/202413:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14/3/202412:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12/3/202412:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11/3/202412:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29/2/202413:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
23/2/202423:28EDGAR2Form D - Notice of Exempt Offering of Securities
22/2/202413:00GLOBEAutolus Therapeutics announces publication in Nature..
21/2/202423:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/2/202414:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202422:17EDGAR2Form 8-K - Current report
08/2/202413:00GLOBEAutolus Announces Pricing of Underwritten Offering
08/2/202412:06EDGAR2Form 8-K - Current report
08/2/202411:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
08/2/202404:00EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31/1/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202419:02EDGAR2Form 8-K - Current report
23/1/202413:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
22/1/202413:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
22/1/202413:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
10/1/202421:12EDGAR2Form 8-K - Current report
10/1/202413:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
22/12/202314:24EDGAR2Form 8-K - Current report
22/12/202313:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
11/12/202314:31EDGAR2Form 8-K - Current report
10/12/202302:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
28/11/202320:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202313:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
27/11/202313:07EDGAR2Form 8-K - Current report
27/11/202313:00GLOBEAutolus Therapeutics Submits Biologics License Application..
15/11/202313:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
09/11/202322:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:18EDGAR2Form 8-K - Current report
06/11/202313:00GLOBEAutolus Therapeutics announces participation in upcoming..
03/11/202321:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/11/202321:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202314:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
02/11/202312:11GLOBEAutolus Therapeutics Reports Third Quarter 2023 Financial..
17/10/202313:00GLOBEAutolus Therapeutics to host virtual event to discuss the..
11/10/202314:07GLOBECorrection - Autolus Therapeutics to report third quarter..
11/10/202313:00GLOBEAutolus Therapeutics to report third quarter 2023 financial..
05/9/202313:00GLOBEAutolus Therapeutics announces data from AUTO1/22 trial in..
07/8/202322:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/8/202322:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202313:00GLOBEAutolus Therapeutics Reports Second Quarter 2023 Financial..
21/7/202322:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/7/202313:00GLOBEAutolus Therapeutics to report second quarter 2023 financial..

Dernières Valeurs Consultées

NASDAQ
AUTL
Autolus Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés